OBJECTIVE: To compare the mean nocturnal blood pressure of patients with various forms of renal and endocrine hypertension with that in patients with primary and white coat hypertension, and normal blood pressure. DESIGN: Ambulatory monitoring of blood pressure over 24 hours in a prospective study. SETTING: Two German centres for outpatients with hypertension and kidney diseases. SUBJECTS: 176 normotensive subjects, 490 patients with primary hypertension including mild and severe forms, 42 with white coat hypertension, 208 patients with renal and renovascular hypertension, 43 with hypertension and endocrine disorders, and three with coarctation of the aorta. MAIN OUTCOME MEASURES: Fall in nocturnal blood pressure. RESULTS: Blood pressure in normotensive subjects fell by a mean of 14 mm Hg (11%) systolic and 13 mm Hg (17%) diastolic overnight (2200 to 0600). The falls in patients with primary and white coat hypertension were not significantly different. In all patients with renal and renovascular hypertension, however, the fall was significantly reduced (range of fall from 3/3 mm Hg to 7/9 mm Hg). In patients with hypertension and endocrine disorders the pattern of night time blood pressure was not uniform: patients with hyperthyroidism, primary hyperaldosteronism, and Cushing's syndrome had significantly smaller reductions in blood pressure (6/8, 4/7, 3/6 mm Hg, respectively). In patients with phaeochromocytoma the mean night time blood pressure increased by 4/2 mm Hg. In patients with hypertension, primary hyperparathyroidism, and unoperated coarctation of the aorta the falls in blood pressure were normal. CONCLUSIONS: In normotensive subjects and those with primary hypertension there is usually a reduction in blood pressure at night. In all renal forms of secondary hypertension and in most endocrine forms the reduction in blood pressure is only a third to a half of normal. Patients with primary hyperparathyroidism and unoperated coarctation of the aorta show a normal reduction.
OBJECTIVE: To compare the mean nocturnal blood pressure of patients with various forms of renal and endocrine hypertension with that in patients with primary and white coat hypertension, and normal blood pressure. DESIGN: Ambulatory monitoring of blood pressure over 24 hours in a prospective study. SETTING: Two German centres for outpatients with hypertension and kidney diseases. SUBJECTS: 176 normotensive subjects, 490 patients with primary hypertension including mild and severe forms, 42 with white coat hypertension, 208 patients with renal and renovascular hypertension, 43 with hypertension and endocrine disorders, and three with coarctation of the aorta. MAIN OUTCOME MEASURES: Fall in nocturnal blood pressure. RESULTS: Blood pressure in normotensive subjects fell by a mean of 14 mm Hg (11%) systolic and 13 mm Hg (17%) diastolic overnight (2200 to 0600). The falls in patients with primary and white coat hypertension were not significantly different. In all patients with renal and renovascular hypertension, however, the fall was significantly reduced (range of fall from 3/3 mm Hg to 7/9 mm Hg). In patients with hypertension and endocrine disorders the pattern of night time blood pressure was not uniform: patients with hyperthyroidism, primary hyperaldosteronism, and Cushing's syndrome had significantly smaller reductions in blood pressure (6/8, 4/7, 3/6 mm Hg, respectively). In patients with phaeochromocytoma the mean night time blood pressure increased by 4/2 mm Hg. In patients with hypertension, primary hyperparathyroidism, and unoperated coarctation of the aorta the falls in blood pressure were normal. CONCLUSIONS: In normotensive subjects and those with primary hypertension there is usually a reduction in blood pressure at night. In all renal forms of secondary hypertension and in most endocrine forms the reduction in blood pressure is only a third to a half of normal. Patients with primary hyperparathyroidism and unoperated coarctation of the aorta show a normal reduction.
Authors: Y Imai; K Abe; S Sasaki; N Minami; M Nihei; M Munakata; O Murakami; K Matsue; H Sekino; Y Miura Journal: Hypertension Date: 1988-07 Impact factor: 10.190
Authors: D C Kem; M H Weinberger; C Gomez-Sanchez; N J Kramer; R Lerman; S Furuyama; C A Nugent Journal: J Clin Invest Date: 1973-09 Impact factor: 14.808
Authors: S Zacharieva; M Orbetzova; A Stoynev; R Shigarminova; M Yaneva; K Kalinov; E Nachev; A Elenkova Journal: J Endocrinol Invest Date: 2004-11 Impact factor: 4.256
Authors: S Zacharieva; M Orbetzova; A Elenkova; A Stoynev; M Yaneva; R Schigarminova; K Kalinov; E Nachev Journal: J Endocrinol Invest Date: 2006-01 Impact factor: 4.256